Dr. Derek Janssens awarded NIH New Innovator Award for epigenetics research

Dr. Derek Janssens of the Van Andel Institute is among 42 scientists to receive the 2026 New Innovator Award from the NIH Common Fund's High-Risk, High-Reward Program. This award supports his development of new tools to better understand epigenetic regulation of the immune system, which has important implications for cancer, autoimmune disorders, and other diseases. The recognition highlights innovative early-career research addressing major biomedical challenges.

Originally published by gnews